Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ethamsylate
Cat. No.:
0225LY-1127
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ethamsylate is used as a hemostatic agent that works by boosting platelet adhesion and capillary resistance while hindering prostaglandin biosynthesis.
Synonym:
Cyclonamine; Etamsylate; Dicynene; Aglumin; 2624-44-4
CAS No.:
2624-44-4
Formula:
C10H17NO5S
Formula Weight:
263.31
Specification
Relative Density:
1.3441 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ethamsylate can be used in hematological research to study the enhancement of platelet adhesion and capillary wall stability.
Library Information
Target:
Prostaglandin receptor
Receptor:
Prostaglandin receptor
Pathways:
GPCR/G protein signaling; Immunology/Inflammation
Plate Number:
AOCL-15
Plate Location:
e3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 189.89 mM
